|
CTNND1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.20803408679649E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.42619291113533E-12 |
| Normal-vs-Stage2 |
3.159900E-04 |
| Normal-vs-Stage3 |
1.779290E-04 |
| Normal-vs-Stage4 |
2.62939999995382E-07 |
| Stage1-vs-Stage2 |
7.138800E-01 |
| Stage1-vs-Stage3 |
8.095400E-01 |
| Stage1-vs-Stage4 |
4.077600E-01 |
| Stage2-vs-Stage3 |
9.040200E-01 |
| Stage2-vs-Stage4 |
2.911000E-01 |
| Stage3-vs-Stage4 |
3.963800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.79254397383966E-12 |
| Normal-vs-AfricanAmerican |
1.45969999976181E-07 |
| Normal-vs-Asian |
3.13959999997948E-06 |
| Caucasian-vs-AfricanAmerican |
6.328400E-01 |
| Caucasian-vs-Asian |
2.291000E-01 |
| AfricanAmerican-vs-Asian |
1.657610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12496686913255E-13 |
| Normal-vs-Female |
7.53830000000955E-05 |
| Male-vs-Female |
1.929600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.07979996850128E-09 |
| Normal-vs-Extreme_Weight |
1.66211489016632E-12 |
| Normal-vs-Obese |
4.26730000000486E-05 |
| Normal-vs-Extreme_Obese |
1.41290000033045E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.581200E-01 |
| Normal_Weight-vs-Obese |
1.614040E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.121600E-01 |
| Extreme_Weight-vs-Obese |
1.961850E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.890000E-01 |
| Obese-vs-Extreme_Obese |
1.918830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.283200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.76780000030286E-08 |
| Normal-vs-Age(61-80Yrs) |
2.83106871279415E-14 |
| Normal-vs-Age(81-100Yrs) |
2.24050000774412E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.151000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.182810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.578000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.543300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.978190E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.499200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.07870404117716E-11 |
| Normal-VS-Type2 PRCC |
1.63613567139009E-12 |
| Normal-VS-KIRP CIMP |
6.887600E-01 |
| Normal-VS-Unclassified PRCC |
1.202090E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.216090E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.801600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.148000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.488200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.936000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.103390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.92481619321461E-12 |
| Normal-vs-N1 |
3.662800E-03 |
| Normal-vs-N2 |
1.441200E-01 |
| N0-vs-N1 |
1.735640E-01 |
| N0-vs-N2 |
9.288400E-01 |
| N1-vs-N2 |
6.056400E-01 |
|
|
